Julie Champion

Julie Champion

Auto-generated profile, based on publicly available information

Julie Champion

IMT Atlantique, Nantes Université, CNRS/IN2P3, SUBATECH, F-44000 Nantes, France

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 December 2009 in The Journal of Physical Chemistry A
Verified
Journal Article
Closed access
JCJ. Champion
J. Champion
CAC. Alliot
C. Alliot
ERE. Renault
E. Renault
BMB. M. Mokili
B. M. Mokili
MCM. Chérel
M. Chérel
GMG. Montavon
G. Montavon

18 July 2011 in Physical Chemistry Chemical Physics
Verified
Journal Article
Open access
PDF file
JCJulie Champion
Julie Champion
MSMahamadou Seydou
Mahamadou Seydou
ASAndrea Sabatié-Gogova
Andrea Sabatié-Gogova
EREric Renault
Eric Renault
GMGilles Montavon
Gilles Montavon
NGNicolas Galland
Nicolas Galland
A cost-effective computational methodology designed to study astatine (At) chemistry in aqueous solution has been established. It is based on two-component spin–orbit density functional theory calculations and solvation calculations using the conductor-like polarizable continuum model in conjunction with specific astatine cavities. Theoretical calculations are confronted with experimental data measured for complexation reactions between metallic forms of astatine (At+ and AtO+) and inorganic ligands (Cl−, Br− and SCN−). For each reaction, both 1 ∶ 1 and 1 ∶ 2 complexes are evidenced. The experimental trends regarding the thermodynamic constants (K) can be reproduced qualitatively and quantitatively. The mean signed error on computed Log K values is −0.4, which corresponds to a mean signed error smaller than 1 kcal mol−1 on free energies of reaction. Theoretical investigations show that the reactivity of cationic species of astatine is highly sensitive to spin–orbit coupling and solvent effects. At the moment, the presented computational methodology appears to be the only tool to gain an insight into astatine chemistry at a molecular level.

20 February 2013 in The Journal of Physical Chemistry A
Verified
Journal Article
Closed access
JCJulie Champion
Julie Champion
ASAndréa Sabatié-Gogova
Andréa Sabatié-Gogova
FBFadel Bassal
Fadel Bassal
TATahra Ayed
Tahra Ayed
CACyrille Alliot
Cyrille Alliot
GMGilles Montavon
Gilles Montavon

1 June 2016 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
TATahra Ayed
Tahra Ayed
JPJulien Pilmé
Julien Pilmé
DTDavid Teze
David Teze
FBFadel Bassal
Fadel Bassal
JBJacques Barbet
Jacques Barbet
NGNicolas Galland
Nicolas Galland

1 June 2009 in Inorganica Chimica Acta
Verified
Journal Article
Closed access
JCJ. Champion
J. Champion
CAC. Alliot
C. Alliot
SHSandrine Huclier-Markai
Sandrine Huclier-Markai
DDD. Deniaud
D. Deniaud
ZAZ. Asfari
Z. Asfari
GMG. Montavon
G. Montavon

11 May 2012 in Dalton Transactions
Verified
Journal Article
Closed access
PDF file
GMG. Montavon
G. Montavon
ADA. Le Du
A. Le Du
JCJ. Champion
J. Champion
TRT. Rabung
T. Rabung
AMA. Morgenstern
A. Morgenstern
The in vivo212Pb/212Bi generator is promising for application in targeted alpha therapy (TAT) of cancer. One main limitation of its therapeutic application is due to potential release of 212Bi from the radioconjugate upon radioactive decay of the mother nuclide 212Pb, potentially leading to irradiation of healthy tissue. The objective of the present work is to assess whether the chelate CHX-A′′-DTPA (N-(2-aminoethyl)-trans-1,2-diaminocyclohexane-N,N′,N′′-pentaacetic acid) bound to a biological carrier molecule may be able to re-complex released 212Bi under in vivo conditions to limit its translocation from the target site. CHX-A′′-DTPA was bound to bovine gamma globulin (BGG) to mimic a model conjugate and the stability of the Bi-CHX-A′′-DTPA-BGG conjugate was studied in blood serum by ultrafiltration. TRLFS experiments using Cm(III) as a fluorescent probe demonstrated that linking CHX-A′′-DTPA to BGG does not affect the coordination properties of the ligand. Furthermore, comparable stability constants were observed between Bi(III) and free CHX-A′′-DTPA, BGG-bound CHX-A′′-DTPA and DTPA. The complexation constants determined between Bi(III) and the chelate molecules are sufficiently high to allow ultra trace amounts of the ligand to efficiently compete with serum transferrin controlling Bi(III) speciation in blood plasma conditions. Nevertheless, CHX-A′′-DTPA is not able to complex Bi(III) generated in blood serum because of the strong competition between Bi(III) and Fe(II) for the ligand. In other words, CHX-A′′-DTPA is not “selective” enough to limit Bi(III) release in the body when applying the 212Pb/212Bi in vivo generator.